DNA-Binding Specificity and <i>trans</i> -Activating Potential of the Leukemia-Associated E2A-Hepatic Leukemia Factor Fusion Protein
Toshiya Inaba(Hiroshima University), A. Thomas Look(Dana-Farber Cancer Institute), Richard A. Ashmun(St. Jude Children's Research Hospital), Linda H. Shapiro(St. Jude Children's Research Hospital), Bart G. Jones(St. Jude Children's Research Hospital), T. Funabiki(St. Jude Children's Research Hospital), A Sinclair(St. Jude Children's Research Hospital)
Cited by 15
Related Papers
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
|Cancer Cell|2002|1.1k
<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
|The Journal of Experimental Medicine|2007|660
Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish
|Journal of Leukocyte Biology|2006|527